These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 16086620

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
    Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF.
    Biol Psychiatry; 2008 Jun 15; 63(12):1127-34. PubMed ID: 18206856
    [Abstract] [Full Text] [Related]

  • 23. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.
    Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M.
    J Clin Psychiatry; 2003 Aug 15; 64(8):959-65. PubMed ID: 12927014
    [Abstract] [Full Text] [Related]

  • 24. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr 15; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 25. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT, Wu GWY, Rampersaud R, Reus VI, Wolkowitz OM, Mellon SH.
    Psychoneuroendocrinology; 2024 Jul 15; 165():107045. PubMed ID: 38636352
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
    Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N.
    J Clin Psychiatry; 2004 Sep 15; 65(9):1223-7. PubMed ID: 15367049
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH, Entsuah R, Hackett D.
    Int Clin Psychopharmacol; 2002 Nov 15; 17(6):273-80. PubMed ID: 12409680
    [Abstract] [Full Text] [Related]

  • 32. Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.
    De Berardis D, Fornaro M, Anastasia A, Vellante F, Olivieri L, Rapini G, Serroni N, Orsolini L, Valchera A, Carano A, Tomasetti C, Ventriglio A, Bustini M, Pompili M, Serafini G, Perna G, Iasevoli F, Martinotti G, Di Giannantonio M.
    Braz J Psychiatry; 2020 Nov 15; 42(3):317-321. PubMed ID: 32159712
    [Abstract] [Full Text] [Related]

  • 33. [Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].
    Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.
    Encephale; 2005 Nov 15; 31(6 Pt 1):698-704. PubMed ID: 16462689
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec 15; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.
    Agid O, Lerer B.
    Int J Neuropsychopharmacol; 2003 Mar 15; 6(1):41-9. PubMed ID: 12899735
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
    Ozaki N, Otsubo T, Kato M, Higuchi T, Ono H, Kamijima K, ADMIRE Study Group.
    Psychiatry Clin Neurosci; 2015 Jan 15; 69(1):34-42. PubMed ID: 24965202
    [Abstract] [Full Text] [Related]

  • 40. Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
    Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T.
    J Psychiatr Res; 2017 Jun 15; 89():97-104. PubMed ID: 28213170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.